SEC EDGAR filings, ownership reports, and insider transactions for Takeda Vaccines, Inc..
Recent SEC filings for Takeda Vaccines, Inc. including 13F-NT, 4, N-PX and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 13 Nov 2025 | 30 Sep 2025 | 028-24939 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 | 19 Sep 2025 | 17 Sep 2025 | 001-41365 |
| N-PX | Open N-PX document | View SEC filing for N-PX | 21 Aug 2025 | 20 Aug 2025 | 028-24939 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 08 Aug 2025 | 30 Jun 2025 | 028-24939 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 12 May 2025 | 31 Mar 2025 | 028-24939 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 13 Feb 2025 | 30 Sep 2024 | 028-24939 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 13 Feb 2025 | 30 Jun 2024 | 028-24939 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 13 Feb 2025 | 31 Mar 2024 | 028-24939 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 13 Feb 2025 | 31 Dec 2023 | 028-24939 | |
| 13F-NT | Open 13F-NT document | View SEC filing for 13F-NT | 12 Feb 2025 | 31 Dec 2024 | 028-24939 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 | 01 Dec 2022 | 30 Nov 2022 | 001-41365 |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A | 09 May 2022 | 03 May 2022 | 001-41365 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 | 29 Apr 2022 | 28 Apr 2022 | 001-41365 |
Takeda Vaccines, Inc. files with the SEC under CIK 0001905616. This page aggregates EDGAR filings and related ownership activity.